Opportunity ID: 335764

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-340
Funding Opportunity Title: Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.350 — National Center for Advancing Translational Sciences
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Sep 17, 2021
Last Updated Date: Nov 07, 2023
Original Closing Date for Applications: Sep 13, 2024
Current Closing Date for Applications: Nov 07, 2023
Archive Date: Dec 07, 2023
Estimated Total Program Funding:
Award Ceiling: $500,000
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See the Funding Announcement for Full Eligibility Details

Additional Information

Agency Name: National Institutes of Health
Description:

The purpose of the High Impact Specialized Innovation Programs (SIPs) is to support the development and demonstration of unique hub capabilities, research platforms and/or resources to address in a timely manner critical gap areas and/or roadblocks in clinical and translational science at awarded UM1 Clinical and Translational Science Awards (CTSA) Program Hubs (PAR-21-293). Successful programs supported through this funding opportunity are expected to lay a strong foundation for future adoption and/or dissemination of capabilities to additional CTSA Program Hubs.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-340.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date
Closing early per issuance of PAR-24-054 Nov 07, 2023
Sep 17, 2021

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-340
Funding Opportunity Title: Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.350 — National Center for Advancing Translational Sciences
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Sep 17, 2021
Last Updated Date: Nov 07, 2023
Original Closing Date for Applications: Sep 13, 2024
Current Closing Date for Applications: Nov 07, 2023
Archive Date: Dec 07, 2023
Estimated Total Program Funding:
Award Ceiling: $500,000
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See the Funding Announcement for Full Eligibility Details

Additional Information

Agency Name: National Institutes of Health
Description:

The purpose of the High Impact Specialized Innovation Programs (SIPs) is to support the development and demonstration of unique hub capabilities, research platforms and/or resources to address in a timely manner critical gap areas and/or roadblocks in clinical and translational science at awarded UM1 Clinical and Translational Science Awards (CTSA) Program Hubs (PAR-21-293). Successful programs supported through this funding opportunity are expected to lay a strong foundation for future adoption and/or dissemination of capabilities to additional CTSA Program Hubs.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-340.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-340
Funding Opportunity Title: Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.350 — National Center for Advancing Translational Sciences
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 17, 2021
Last Updated Date: Sep 17, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Sep 13, 2024
Archive Date: Oct 19, 2024
Estimated Total Program Funding:
Award Ceiling: $500,000
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See the Funding Announcement for Full Eligibility Details

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of the High Impact Specialized Innovation Programs (SIPs) is to support the development and demonstration of unique hub capabilities, research platforms and/or resources to address in a timely manner critical gap areas and/or roadblocks in clinical and translational science at awarded UM1 Clinical and Translational Science Awards (CTSA) Program Hubs (PAR-21-293). Successful programs supported through this funding opportunity are expected to lay a strong foundation for future adoption and/or dissemination of capabilities to additional CTSA Program Hubs.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-340.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Folder 335764 Full Announcement-PAR-21-340 -> PAR-21-340-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00270595 Dec 26, 2021 Jan 24, 2023 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00268975 Dec 26, 2021 Jan 24, 2022 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00278364 Nov 14, 2022 Nov 08, 2023 View

Package 1

Mandatory forms

335764 RR_SF424_5_0-5.0.pdf

335764 PHS398_CoverPageSupplement_5_0-5.0.pdf

335764 RR_OtherProjectInfo_1_4-1.4.pdf

335764 PerformanceSite_4_0-4.0.pdf

335764 RR_KeyPersonExpanded_4_0-4.0.pdf

335764 RR_Budget_3_0-3.0.pdf

335764 PHS398_ResearchPlan_4_0-4.0.pdf

335764 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

335764 RR_SubawardBudget30_3_0-3.0.pdf

335764 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

335764 RR_SF424_2_0-2.0.pdf

335764 PHS398_CoverPageSupplement_5_0-5.0.pdf

335764 RR_OtherProjectInfo_1_4-1.4.pdf

335764 PerformanceSite_2_0-2.0.pdf

335764 RR_KeyPersonExpanded_2_0-2.0.pdf

335764 RR_Budget_1_4-1.4.pdf

335764 PHS398_ResearchPlan_4_0-4.0.pdf

335764 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

335764 RR_SubawardBudget30_1_4-1.4.pdf

335764 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

335764 RR_SF424_5_0-5.0.pdf

335764 PHS398_CoverPageSupplement_5_0-5.0.pdf

335764 RR_OtherProjectInfo_1_4-1.4.pdf

335764 PerformanceSite_4_0-4.0.pdf

335764 RR_KeyPersonExpanded_4_0-4.0.pdf

335764 RR_Budget_3_0-3.0.pdf

335764 PHS398_ResearchPlan_5_0-5.0.pdf

335764 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

335764 RR_SubawardBudget30_3_0-3.0.pdf

335764 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T03:11:20-05:00

Share This Post, Choose Your Platform!

About the Author: